ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,961 | -20.5% | 987,916 | -0.8% | 0.01% | -20.0% |
| Q2 2023 | $3,724 | +0.2% | 996,275 | -10.3% | 0.02% | -6.2% |
| Q1 2023 | $3,718 | -10.9% | 1,110,715 | +27.9% | 0.02% | -23.8% |
| Q4 2022 | $4,174 | -99.9% | 868,250 | +5.1% | 0.02% | -19.2% |
| Q3 2022 | $4,696,000 | -7.4% | 825,763 | +15.6% | 0.03% | 0.0% |
| Q2 2022 | $5,072,000 | -17.6% | 714,422 | -16.2% | 0.03% | +4.0% |
| Q1 2022 | $6,152,000 | +153.5% | 852,576 | +213.1% | 0.02% | +177.8% |
| Q4 2021 | $2,427,000 | +128.5% | 272,261 | +797.2% | 0.01% | +125.0% |
| Q3 2021 | $1,062,000 | +46.7% | 30,345 | -10.0% | 0.00% | +33.3% |
| Q2 2021 | $724,000 | – | 33,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |